Tác động của độ tuổi lên việc đảo ngược tình trạng khối cơ do rocuronium gây ra bằng sugammadex ở trẻ em Trung Quốc: một thử nghiệm pilot triển vọng
Tóm tắt
Từ khóa
#sugammadex #khối cơ do rocuronium #trẻ em #phục hồi #nghiên cứu lâm sàngTài liệu tham khảo
Meretoja OA. Neuromuscular block and current treatment strategies for its reversal in children. Paediatr Anaesth. 2010;20:591–604.
Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111:120–8.
Ammar AS, Mahmoud KM, Kasemy ZA. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children. Acta Anaesthesiol Scand. 2017;61:374–80.
Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042–8.
Ledowski T, O’Dea B, Meyerkort L, Hegarty M, von Ungern-Sternberg BS. Postoperative residual neuromuscular paralysis at an Australian tertiary children’s hospital. Anesthesiol Res Pract. 2015;2015:410248.
Johnell K, Fastbom J. Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients. Drugs Aging. 2008;25:871–7.
Iwasaki H, Renew JR, Kunisawa T, Brull SJ. Preparing for the unexpected: special considerations and complications after sugammadex administration. BMC Anesthesiol. 2017;17:140.
Adam JM, Bennett DJ, Bom A, Clark JK, Feilden H, Hutchinson EJ, et al. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. J Med Chem. 2002;45:1806–16.
Matsui M, Konishi J, Suzuki T, Sekijima C, Miyazawa N, Yamamoto S. Reversibility of Rocuronium-induced deep neuromuscular block with Sugammadex in infants and children-a randomized study. Biol Pharm Bull. 2019;42:1637–40.
Tobias JD. Current evidence for the use of sugammadex in children. Paediatr Anaesth. 2017;27:118–25.
Won YJ, Lim BG, Lee DK, Kim H, Kong MH, Lee IO. Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95:e4678.
Yung M, Keeley S. Randomised controlled trial of intravenous maintenance fluids. J Paediatr Child Health. 2009;45:9–14.
Templeton TW, Goenaga-Díaz EJ, Downard MG, McLouth CJ, Smith TE, Templeton LB, et al. Assessment of common criteria for awake extubation in infants and young children. Anesthesiology. 2019;131:801–8.
Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JH, et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology. 2009;110:284–94.
Chow SC, Shao J, Wang HS, Lokhnygina Y. Sample size calculations in clinical research. 3rd ed. Boca Raton: CRC Press; 2018.
Xiaobing L, Yan J, Wangping Z, Rufang Z, Jia L, Rong W. Effects of sugammadex on postoperative respiratory management in children with congenital heart disease: a randomized controlled study. Biomed Pharmacother. 2020;127:110180.
Kawana S, Wachi J, Nakayama M, Namiki A. Comparison of haemodynamic changes induced by sevoflurane and halothane in paediatric patients. Can J Anaesth. 1995;42:603–7.